Showing page 8 of 8 - total 77 results found.
-
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
https://clinicaltrials.llu.edu/trials/equity-modifying-plaque-women-undertr...Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease. Conditions Coronary Artery Disease … -
Evaluation of Tonabersat for DME
https://clinicaltrials.llu.edu/trials/evaluation-tonabersat-dmeThis randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and good visual acuity. Conditions Diabetic Macular Edema … -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
https://clinicaltrials.llu.edu/trials/research-study-see-how-well-cagrisema...The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two medicines called semaglutide and cagrilintide. CagriSema will be compared to the two medicines semaglutide … -
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
https://clinicaltrials.llu.edu/trials/study-orforglipron-ly3502970-particip...The main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and have inadequate glycemic control with insulin glargine with or without metformin and/or SGLT-2 (sodium-glucose … -
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
https://clinicaltrials.llu.edu/trials/research-study-see-how-much-cagrisema...This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a medicine called … -
Cancer Clinical Trials
https://clinicaltrials.llu.edu/cancer-clinical-trialsView the clinical trials open to adults and kids at our Cancer Center. Participate in studies that may offer new ways to treat and diagnose cancer. … cancer trials … cancer studies … cancer research … oncology … Cancer Clinical … -
Dental Clinical Trials
https://clinicaltrials.llu.edu/dental-clinical-trialsContact us to learn about current open studies and clinical trials for adults and kids at our Dental Research Clinic. Participate in studies that may offer new ways to treat and diagnose oral and dental health conditions. … dental trials … dental studies …